Your browser doesn't support javascript.
loading
Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration.
Ahmadzadehfar, Hojjat; Meyer, Carsten; Pieper, Claus Christian; Bundschuh, Ralph; Muckle, Marianne; Gärtner, Florian; Schild, Hans Heinz; Essler, Markus.
Affiliation
  • Ahmadzadehfar H; Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany. Hojjat.ahmadzadehfar@ukb.uni-bonn.de.
  • Meyer C; Department of Radiology, University Hospital Bonn, Bonn, Germany.
  • Pieper CC; Department of Radiology, University Hospital Bonn, Bonn, Germany.
  • Bundschuh R; Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany.
  • Muckle M; Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany.
  • Gärtner F; Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany.
  • Schild HH; Department of Radiology, University Hospital Bonn, Bonn, Germany.
  • Essler M; Department of Nuclear Medicine, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Germany.
EJNMMI Res ; 5(1): 54, 2015 Dec.
Article in En | MEDLINE | ID: mdl-26463848
ABSTRACT

BACKGROUND:

The purpose of this study is to evaluate the impact of switching from sterile water to 5 % glucose (G5W) for the administration of yttrium-90 ((90)Y)-resin microspheres on the total activity of (90)Y administered (expressed as a proportion of the prescribed/calculated activity), as well as the number of cases of stasis and the reported incidence of discomfort during the selective internal radiation therapy (SIRT) procedure.

METHODS:

In December 2013, we switched from sterile water to G5W for the administration of SIRT using (90)Y resin microspheres in all patients. This retrospective observational single-center case series describes our experience in the months preceding and after the switch. Apart from the change in administration medium, the protocol for SIRT was otherwise identical.

RESULTS:

One hundred and four SIRT procedures were performed on 78 patients (45 male, mean age 63 years, range 31-87 years) with either unresectable hepatocellular carcinoma, cholangiocarcinoma, or chemorefractory liver-dominant metastatic cancer. Compared with sterile water, the whole prescribed activity was administered in significantly more procedures with G5W 85 vs. 22 %; p < 0.0001. A significantly higher proportion of the calculated activity was administered with G5W 96.1 ± 11.0 % vs. 77.4 ± 24.3 % (p < 0.0001). G5W procedures were also associated with a significantly lower incidence of stasis (28 vs. 11 % procedures; p = 0.02) and mild-to-moderate upper abdominal pain during the procedure (1.8 vs. 44 % procedures; p < 0.0001).

CONCLUSIONS:

Replacing sterile water with isotonic G5W during administration favorably impacts on the safety of SIRT, eliminates and/or minimizes flow reductions and stasis/reflux during administration of (90)Y resin microspheres, improves percentage activity delivered, and reduces peri-procedural pain.
Key words

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2015 Type: Article

Full text: 1 Database: MEDLINE Type of study: Guideline Language: En Year: 2015 Type: Article